0001140361-24-009271.txt : 20240223 0001140361-24-009271.hdr.sgml : 20240223 20240223163735 ACCESSION NUMBER: 0001140361-24-009271 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240221 FILED AS OF DATE: 20240223 DATE AS OF CHANGE: 20240223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harris Theodore L CENTRAL INDEX KEY: 0001378228 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13648 FILM NUMBER: 24672022 MAIL ADDRESS: STREET 1: 5200 BLAZER PARKWAY CITY: DUBLIN STATE: OH ZIP: 43017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BALCHEM CORP CENTRAL INDEX KEY: 0000009326 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 132578432 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 PARAGON DRIVE CITY: MONTVALE STATE: NJ ZIP: 07645 BUSINESS PHONE: (845) 326-5600 MAIL ADDRESS: STREET 1: 5 PARAGON DRIVE CITY: MONTVALE STATE: NJ ZIP: 07645 4 1 form4.xml X0508 4 2024-02-21 0000009326 BALCHEM CORP BCPC 0001378228 Harris Theodore L C/O BALCHEM CORPORATION 5 PARAGON DRIVE MONTVALE NJ 07645 true true Chairman, President & CEO false Common Stock 2024-02-21 4 S 0 10797 152.9738 D 85294 D Common Stock 2024-02-21 4 S 0 16015 153.7461 D 69279 D Common Stock 2024-02-21 4 S 0 2667 154.8359 D 66612 D Common Stock 2024-02-21 4 S 0 200 155.91 D 66412 D Common Stock 2024-02-22 4 M 0 10000 54.87 A 76412 D Common Stock 2024-02-22 4 M 0 24350 60.85 A 100762 D Common Stock 2024-02-22 4 S 0 14497 153.5564 D 86265 D Common Stock 2024-02-22 4 S 0 13989 154.66 D 72276 D Common Stock 2024-02-22 4 S 0 5864 155.249 D 66412 D Stock Options (right to buy) 54.87 2024-02-22 4 M 0 10000 0 A 2025-04-28 Common Stock 10000 0 D Stock Options (right to buy) 60.85 2024-02-22 4 M 0 24350 0 A 2026-02-23 Common Stock 24350 0 D This transaction was executed in multiples sales ranging from $152.3350 to $153.3200 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. This transaction was executed in multiples sales ranging from $153.3400 to $154.2900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. This transaction was executed in multiples sales ranging from $154.4700 to $155.3800 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Exercise of fully vested non-qualified stock options. This transaction was executed in multiple sales ranging from $153.0800 to $154.0775 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. This transaction was executed in multiple sales ranging from $154.0800 to $155.0750 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. This transaction was executed in multiple sales ranging from $155.0800 to $155.5700 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Stock options that vested 20% on April 28, 2016, 40% on April 28, 2017, and 40% on April 28, 2018, and are exercisable. Stock options that vested 20% on February 23, 2017, 40% on February 23, 2018, and 40% on February 23, 2019, and are exercisable. /s/ Travis Larsen, Attorney in Fact for Theodore L. Harris 2024-02-23